Both biotechs are a bit risky, but could benefit from clinical progress this year -- and the upside would be huge. CRISPR has ...

Verified Market Research® a leading provider of business intelligence and market analysis is thrilled to announce the release of its comprehensive and authoritative report on the, " Stem Cell Therapy ...

Basecamp Research, a frontier AI lab harnessing evolution to design new medicines, today announced the first AI models capable of programmable gene insertion, offering a new way to replace faulty ...

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today highlighted its strategic priorities and anticipated ...

Tom Yeung here with your Sunday Digest. In 2007, the hit TV show South Park introduced one of its most memorable characters ...

Growth expectations for this other trillion-dollar company are more modest, but it could easily beat them and grow even ...

Congratulations to the green sea turtle, which is off the endangered species list as of 2025 thanks to a population rebound.

Detailed price information for Beam Therapeutics Inc (BEAM-Q) from The Globe and Mail including charting and trades.

Contrarius Investment Management, an investment management company, released its third-quarter investor letter for the ...

Cathie Wood’s Ark Invest increased exposure to gene-editing names and autonomous mobility companies while further cutting ...

CRISPR Therapeutics (NASDAQ:CRSP) is one of the best emerging technology stocks to invest in. On December 22, CRISPR Therapeutics released a comprehensive clinical update on zugocaptagene geleucel ...

Shares of chipmaker Micron Technology Inc (NASDAQ:MU) briefly hit a fresh record high for a fifth-straight session before edging down 0.5% to trade at $285.21. The move reflects an extension of the ...